This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Pathology and diagnostics
The importance of diagnostic procedures in ensuring healthcare quality
Read more
Point-of-care ultrasound invaluable for treatment of ICU patients
Read more
Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing
Read more
Adding value to the healthcare system
Read more
Liquid biopsies in clinical practice
Read more
Component resolved diagnostics in allergology
Read more
Personalising therapies in primary osteoporosis
Read more
HCV genotyping by next generation sequencing
Read more
North West trusts take ‘giant leap’ in connecting diagnostics across hospitals
Read more
Integrating diagnostics: not a takeover but fundamental to better care
Read more
Candidate metabolomic network for bladder cancer diagnostics
Read more
New radiopharmaceutical offers next-generation standard of diagnosis
Read more
Breakthrough in detection of cancers
Read more
Phillips and LabPON to create largest pathology learning database for annotated tissue images
Read more
Hospital introduces Phillips Minicare cTnI point of care blood test for suspected heart attack patients
Read more
Philips and Diagnostics Development win EU ‘Horizon Prize – Better Use of Antibiotics’
Read more
Next generation Proxima™ launched – delivering bedside blood gas and glucose analysis
Read more
Page 12 of 21
« First
«
...
10
11
12
13
14
...
20
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: